Filing Details

Accession Number:
0000899243-21-033963
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-23 19:00:20
Reporting Period:
2021-08-18
Accepted Time:
2021-08-23 19:00:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800682 Cano Health Inc. CANO Services-Offices & Clinics Of Doctors Of Medicine (8011) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1865483 Marlow Hernandez Cano Health, Inc.
9725 Nw 117Th Avenue, Suite 200
Miami FL 33178
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-08-18 11,900 $9.82 221,900 No 4 P Direct
Class A Common Stock Acquisiton 2021-08-19 25,000 $10.38 246,900 No 4 P Direct
Class A Common Stock Acquisiton 2021-08-20 10,000 $10.20 256,900 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Warrants to purchase Class A Common Stock Acquisiton 2021-08-18 1,832 $2.30 1,832 $11.50
Class A Common Stock Warrants to purchase Class A Common Stock Acquisiton 2021-08-19 15,000 $2.89 15,000 $11.50
Class A Common Stock Warrants to purchase Class A Common Stock Acquisiton 2021-08-20 5,000 $2.75 5,000 $11.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
251,832 2021-07-03 2026-06-04 No 4 P Direct
266,832 2021-07-03 2026-06-04 No 4 P Direct
271,832 2021-07-03 2026-06-04 No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.40 to $9.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(3) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.25 to $10.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $2.86 to $2.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(3) to this Form 4.